We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 367.50
Bid: 367.00
Ask: 367.50
Change: 4.00 (1.10%)
Spread: 0.50 (0.136%)
Open: 371.00
High: 371.00
Low: 363.00
Prev. Close: 363.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Scheme Meetings & Annual General Meeting

26 Apr 2023 16:41

RNS Number : 5931X
Breedon Group PLC
26 April 2023
 

26 April 2023

BREEDON GROUP PLC

Result of Scheme Meetings and Annual General Meeting

On 29 March 2023, Breedon Group plc (the "Company" and together with its subsidiaries, "Breedon" or the "Group") announced the publication of the circular (the "Scheme Document") in relation to the proposed reorganisation of the Group by which a new holding company of the Group incorporated in England and Wales ("New Breedon") would be introduced by way of a scheme of arrangement (the "Scheme").

The board of directors of Breedon announce that a Jersey court meeting (the "Court Meeting") was convened today at 2:15pm to approve the Scheme, and a scheme general meeting (the "Scheme General Meeting") to approve the special resolution, as detailed within Part 8 of the Scheme Document, occurred thereafter at 2:30pm.

The Company is pleased to announce that all resolutions proposed at the Court Meeting and Scheme General Meeting were duly passed by the requisite majority of shareholders. The resolutions and voting outcomes are set out below. Capitalised terms used in this announcement shall, unless otherwise defined, have the meanings set out in Part 8 of the Scheme Document

Results of the Court Meeting

At the Court Meeting, a majority in number of Scheme Shareholders who voted (either in person or by proxy), representing 73.37 per cent by value of those Scheme Shares voted, voted in favour of the resolution to approve the Scheme. The table below sets out the results of the resolution proposed at the Court Meeting:

 

Number of Scheme Shares voted

% of Scheme Shares voted

Number of Scheme Shareholders who voted

% of Scheme Shareholders who voted

Number of Scheme Shares voted as a % of the issued share capital entitled to vote on the Scheme

For

1,243,229,157

94.19

212

90.21

73.37

Against

76,686,943

5.81

23

9.79

4.53

Total

1,319,916,100

100.00

235

100.00

77.90

 

Results of the Scheme General Meeting

At the Scheme General Meeting, the special resolution to authorise (amongst other things) the implementation of the Scheme was duly passed by Breedon Shareholders. The table below sets out the results of the resolution proposed at the Scheme General Meeting:

 

Number of Breedon Shares voted

% of Breedon Shares voted

For

1,237,447,466

94.16

Against

76,694,951

5.84

Total

1,314,142,417

100.00

 

Annual General Meeting

The Annual General Meeting of Breedon (the "AGM") was also held on 26 April 2023 at Pinnacle House, Breedon on the Hill, Derby, DE73 8AP at 2:00pm.

All resolutions were duly passed on a poll and the results of each resolution were as follows:

Ordinary resolutions:

Votes for

% in favour

Votes against

Votes total

Votes withheld

1

To adopt the Financial Statements and the reports of the Directors and of the Auditor for the year ended 31 December 2022

1,309,253,031

100.00

59,290

1,312,118,841

2,806,520

2

To reappoint the Auditor

1,305,015,300

99.47

6,902,031

1,312,118,841

201,510

3

To authorise Directors to determine the fee payable to the Auditor

1,310,717,878

99.91

1,232,752

1,312,118,841

168,211

4

To approve the Directors' Remuneration Report

1,275,901,377

97.26

35,911,563

1,312,118,841

305,901

5

To approve a final dividend

1,311,947,743

100.00

24,230

1,312,118,841

146,868

6

To reappoint Amit Bhatia as a Director of the Company

1,300,488,958

99.13

11,353,567

1,312,118,841

276,316

7

To reappoint James Brotherton as a Director of the Company

1,307,858,163

99.69

4,002,475

1,312,118,841

258,203

8

To reappoint Carol Hui as a Director of the Company

1,309,336,387

99.80

2,596,908

1,312,118,841

185,546

9

To reappoint Pauline Lafferty as a Director of the Company

1,280,298,753

97.59

31,559,502

1,312,118,841

260,586

10

To reappoint Helen Miles as a Director of the Company

1,309,259,324

99.80

2,598,617

1,312,118,841

260,900

11

To reappoint Clive Watson as a Director of the Company

1,305,277,175

99.50

6,565,036

1,312,118,841

276,630

12

To reappoint Rob Wood as a Director of the Company

1,308,541,595

99.75

3,319,043

1,312,118,841

258,203

13

To authorise Directors to allot shares

1,271,179,886

96.89

40,741,010

1,312,118,841

197,945

 

 

Special resolutions:

Votes for

% in favour

Votes against

Votes total

Votes withheld

14

To disapply pre-emption rights in relation to the allotment of shares

1,281,046,805

97.64

30,898,323

1,312,118,841

173,713

15

To authorise the Directors to allot shares issued for an acquisition without applying pre-emption rights

1,218,490,151

92.88

93,454,278

1,312,118,841

174,412

16

To authorise the Company to purchase its own shares

1,231,234,363

99.53

5,796,960

1,312,118,841

75,087,518

 

Notes:

1. Votes 'For' include those votes giving the Chair discretion.

2. The number of ordinary shares in issue at 6.00 p.m. on 24 April 2023 was 1,694,428,520. Shareholders are entitled to one vote per share. 

3. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.

 

Next Steps

The Scheme remains subject to the approval of the Court at the hearing scheduled for 9:00am on 16 May 2023, and certain other conditions as set out in Part 2 of the Scheme Document.

The indicative timetable of the key milestones outstanding under the Scheme remains as set out on page 9 of the Scheme Document and is also set out below:

 

The following dates are indicative only and are subject to change1

Expected date of publication of the Prospectus by New Breedon

11 May 2023

Sanction Hearing (to sanction the Scheme)

9.00 a.m. on 16 May 2023

Scheme Record Time

6.00 p.m. on 16 May 2023

Last day of dealings in, and for the registration of transfers of, and disablement in CREST of, Breedon Shares on AIM

16 May 2023

Effective Date

16 May 20232

Cancellation of admission to trading of Breedon Shares on AIM

by 8.00 a.m. on 17 May 2023

Admission of New Breedon Shares to listing on the premium listing segment of the Official List and to trading on the Main Market and commencement of dealings

8.00 a.m. on 17 May 2023

Crediting of New Breedon Shares to CREST accounts

8.00 a.m. on 17 May 2023

Share certificates for New Breedon Shares expected to be despatched within 10 Business Days of Admission

by 1 June 2023

Long Stop Date

30 June 20233

 

 

1. These dates are indicative only and will depend, among other things, on the date upon which: (i) the Conditions are satisfied or (if capable of waiver) waived; (ii) the Court sanctions the Scheme; and (iii) the Court Order is delivered to the Jersey Registrar of Companies. Participants in Breedon Share Plans will be contacted separately to inform them of the effect of the Scheme on their rights under Breedon Share Plans, including details of any appropriate proposals being made and dates and times relevant to them.

2. Following sanction of the Scheme by the Court, the Scheme will become Effective in accordance with its terms upon a copy of the Court Order being delivered to the Jersey Registrar of Companies. This is presently expected to occur on 16 May 2023, subject to satisfaction or (where capable of waiver), waiver of the Conditions.

3. This is the latest date by which the Scheme may become Effective. However, the Long Stop Date may be extended to such later date as Breedon and New Breedon may agree (and as the Court may allow, should such approval be required).

 

Enquiries:

Breedon Group plc

+44 (0) 1332 694010

Rob Wood, Chief Executive Officer

James Brotherton, Chief Financial Officer

Louise Turner-Smith, Head of Investor Relations

+44 (0) 7860 911909

 

Moelis (Financial Adviser to Breedon)

+44 (0) 207 634 3500

Mark Aedy, Daniel Muldoon, Andrew Welby

 

Numis (Sponsor, NOMAD and joint broker)

+44 (0) 20 7260 1000

Ben Stoop, Oliver Hardy (NOMAD)

 

HSBC (Joint broker)

+44 (0) 20 7991 8888

Sam McLennan, Joe Weaving

 

MHP (Public relations adviser)

+44 (0) 20 3128 8193

Reg Hoare, Rachel Farrington, Charles Hirst

breedon@mhpgroup.com

 

 

About Breedon Group plc

Breedon Group plc, a leading vertically-integrated construction materials group in Great Britain and Ireland, delivers essential products to the construction sector. Breedon holds 1bn tonnes of mineral reserves and resources with long reserve life, supplying value-added products and services, including specialty materials, surfacing and highway maintenance operations, to a broad range of customers through its extensive local network of quarries, ready-mixed concrete and asphalt plants.

The Group's two well-invested cement plants are actively engaged in a number of carbon reduction practices, which include utilising alternative raw materials and lower carbon fuels. Breedon's 3,700 colleagues embody our commitment to 'Make a Material Difference' as the Group continues to execute its strategy to create sustainable value for all stakeholders, delivering growth through organic improvement and acquisition in the heavyside construction materials market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMDZGZDKVGGFZM
Date   Source Headline
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.